title: Hematopoietic prostaglandin D synthase inhibitors.
authors.affiliation: Molecular Innovative Therapeutics, Sanofi Pharmaceuticals, Bridgewater, NJ, USA.
authors.forename: Sukanthini
authors.initials: S
authors.lastname: Thurairatnam
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy; D000818:Animals; D001249:Asthma / Q000188:drug therapy; D003876:Dermatitis, Atopic / Q000188:drug therapy; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000737:chemistry* / Q000494:pharmacology* / Q000627:therapeutic use*; D006801:Humans; D019746:Intramolecular Oxidoreductases / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism*; D007965:Leukodystrophy, Globoid Cell / Q000188:drug therapy; D054834:Lipocalins / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism*; D009136:Muscular Dystrophies / Q000188:drug therapy; D009536:Niacinamide / Q000031:analogs & derivatives / Q000737:chemistry; D010880:Piperidines / Q000737:chemistry; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy; D011720:Pyrazoles / Q000737:chemistry; D011743:Pyrimidines / Q000737:chemistry; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy; D013119:Spinal Cord Injuries / Q000188:drug therapy; D013844:Thiazoles / Q000737:chemistry
chemical_list: D004791:Enzyme Inhibitors; D054834:Lipocalins; D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines; D013844:Thiazoles; D009536:Niacinamide; D019746:Intramolecular Oxidoreductases; C022466:prostaglandin R2 D-isomerase; C030986:pyrimidine